Sonoma Pharmaceuticals (SNOA) Total Liabilities (2011 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Total Liabilities of $10.9 million for Q1 2026, up 17.05% year-over-year from $9.3 million in Q1 2025, and up 6.61% quarter-over-quarter from $10.2 million in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Total Liabilities (2011 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Total Liabilities history runs 16 years deep, the most recent figure standing at $10.9 million for Q1 2026.
- In Q1 2026, Total Liabilities rose 17.05% year-over-year to $10.9 million; the TTM figure through Mar 2026 stood at $10.9 million (up 17.05% YoY), while the FY2026 annual figure was $10.9 million, up 17.05% from the prior year.
- Total Liabilities for Q1 2026 stood at $10.9 million, up from $10.2 million in the prior quarter.
- The five-year high for Total Liabilities was $10.9 million in Q1 2026, with the low at $7.9 million in Q4 2023.
- The 5-year median for Total Liabilities is $8.7 million (2024), against an average of $9.0 million.
- The sharpest annual moves came in 2023 and 2025: Total Liabilities slipped 18.66% in 2023, then rose 21.15% in 2025.
- Sonoma Pharmaceuticals' Total Liabilities stood at $8.4 million in 2022, then fell by 5.29% to $7.9 million in 2023, then advanced by 11.0% to $8.8 million in 2024, then climbed by 15.83% to $10.2 million in 2025, then increased by 6.61% to $10.9 million in 2026.
- Business Quant data shows SNOA's Total Liabilities at $10.9 million in Q1 2026, $10.2 million in Q4 2025, and $10.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 2.12 Bn |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn | 11.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.51 Mn |
| Mar 31, 2026 | 10.87 Mn |
| Dec 31, 2025 | 10.19 Mn |
| Sep 30, 2025 | 10.07 Mn |
| Jun 30, 2025 | 10.54 Mn |
| Mar 31, 2025 | 9.28 Mn |
| Dec 31, 2024 | 8.80 Mn |
| Sep 30, 2024 | 8.33 Mn |
| Jun 30, 2024 | 8.70 Mn |
| Mar 31, 2024 | 8.60 Mn |
| Dec 31, 2023 | 7.93 Mn |
| Sep 30, 2023 | 7.96 Mn |
| Jun 30, 2023 | 8.65 Mn |
| Mar 31, 2023 | 8.25 Mn |
| Dec 31, 2022 | 8.37 Mn |
| Sep 30, 2022 | 7.94 Mn |
| Jun 30, 2022 | 9.20 Mn |
| Mar 31, 2022 | 10.15 Mn |
| Dec 31, 2021 | 8.18 Mn |
| Sep 30, 2021 | 8.37 Mn |